Indaptus Therapeutics, Inc. (INDP)
1.22
+0.16
(+15.09%)
USD |
NASDAQ |
May 22, 16:00
1.24
+0.02
(+1.64%)
After-Hours: 20:00
Indaptus Therapeutics EPS Diluted (Quarterly) : -0.2319 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| ANIKA THERAPEUTICS INC | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.541M |
| Total Expenses (Quarterly) | 2.541M |
| Enterprise Value | 136.66M |
| Earnings Yield | -1.32K% |
| Normalized Earnings Yield | -1214.09 |